SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Grand Pharmaceutical Says CBT-001 Phase III Trial Meets Primary Endpoint

Grand Pharmaceutical said its CBT-001 Phase III trial reached its primary clinical endpoint.

Related stories